Gardasil 9, Injektionssuspension in Fertigspritze - 10 Swissmedic Key 65387002 PP Registration Holder MSD Merck Sharp & Dohme AG Name Gardasil 9, Injektionssuspension in Fertigspritze Date of registration 29.07.2016 Introduction of Sequence 29.07.2016 ATC-Classification Papillomavirus (Human Types 6, 11, 16, 18, 31, 33, 45, 52, 58) (J07BM03) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) Show package size 10 Index Therapeuticus (Swissmedic) 08.08. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals IP Consumer information Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680653870026 Medication Code Impfstoffe Pharmacode Disponibility
Composition proteinum L1 papillomaviri humani typus 6 30 µg, proteinum L1 papillomaviri humani typus 11 40 µg, proteinum L1 papillomaviri humani typus 16 60 µg, proteinum L1 papillomaviri humani typus 18 40 µg, proteinum L1 papillomaviri humani typus 31 20 µg, proteinum L1 papillomaviri humani typus 33 20 µg, proteinum L1 papillomaviri humani typus 45 20 µg, proteinum L1 papillomaviri humani typus 52 20 µg, proteinum L1 papillomaviri humani typus 58 20 µg, aluminium ut aluminii hydroxyphosphas sulfas amorphus, natrii chloridum, histidinum, polysorbatum 80, natrii boras, aqua ad iniectabile ad suspensionem pro 0.5 ml corresp. natrium 3.78 mg. Packungsbestandteile Galenic Form Excipiens Active Agent Dose 40µg / 0.5ml 60µg / 0.5ml 40µg / 0.5ml 20µg / 0.5ml 20µg / 0.5ml 20µg / 0.5ml 20µg / 0.5ml 20µg / 0.5ml 30µg / 0.5ml
Inactive agents Alumine Histidine Sodium Chloride Polysorbatum 80
Source Data was imported : 06.01.2022
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
